Brief: Clene's CNM-AU8 ALS And MS Clinical Data Featured At 2023 American Academy Of Neurology Annual Meeting
25/04/2023 22:11
April 25 (Reuters) - Clene Inc. CLNN.O :
* ALS AND MS CLINICAL DATA FROM CLENE’S CNM-AU8® FEATURED IN
MULTIPLE PRESENTATIONS AT THE 2023 AMERICAN ACADEMY OF NEUROLOGY
ANNUAL MEETING
Source text for Eikon: ID:nGNX77PNFS
Further company coverage: CLNN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clene
See all newsClene Inc reports results for the quarter ended June 30 - Earnings Summary
Clene Q2 net loss widens on higher other expenses
Clene Inc expected to post a loss of 37 cents a share - Earnings Preview
Brief: Clene Inc - Enters Second Amendment To Senior Secured Convertible Notes - SEC Filing
Clene Q1 loss widens on warrant liability issuance costs